跳至主要内容
临床试验/NL-OMON55611
NL-OMON55611已完成2 期

Perifere histamine 1 receptor blokkade in PDS - Peripheral histamine 1 receptor blockade in IBS

Z Leuven0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1. Patients meet the ROME III criteria for IBS and is NOT diagnosed with the
  • constipation dominant subform of IBS (IBS-C), 2. No identifiable organic
  • explanation for the symptoms (including the execution of a test for lactose
  • intolerance, celiac disease and giardia test), 3. Age 18-65 years, 4. Signed
  • informed consent, 5. Symptoms during the two weeks of screening

排除标准

  • 1. IBS constipation dominant, 2. Patient with history of:, Celiac disease,
  • Known milk allergy, giardiasis, inflammatory bowel disease, active intestinal
  • infection, chronic intestinal ischemia, chronic subobstruction,
  • pseudo-obstruction, dumping syndrome, pancreatic insufficiency, hepatic
  • impairment, renal function impairment, cardiovascular disease, extensive
  • gastrectomy and/or bowel resection, active malignant disease,
  • thyroiddysfunction, insulin dependent diabetes mellitus, psychiatric disorder,
  • any clinical condition in which the researcher does not allow to terminate the
  • study safely, 3. Pregnancy, breastfeeding, 4. Medication: Use of
  • anti-allergica, antidepressants, and antipsychotics, 5. Patient uses drugs that
  • reduce gastrointestinal motility and / or affect the visceral perception
  • (anticholinergics, antispasmodics, 5-HT4 agonists, cholinomimetics, loperamide,
  • laudanum, codeine, stimulant laxatives, macrogol, paraffin oil,
  • anti-inflammatory agents) OR mediaction knwon to prolong QTc-interval
  • (antifungals (ketoconazol) and macrolides (erytromycien, claritromycine))., 6.
  • Complaints arise after abdominal surgery

研究者

发起方
Z Leuven

相似试验